KR100754953B1 - 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 - Google Patents
유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 Download PDFInfo
- Publication number
- KR100754953B1 KR100754953B1 KR1020050085718A KR20050085718A KR100754953B1 KR 100754953 B1 KR100754953 B1 KR 100754953B1 KR 1020050085718 A KR1020050085718 A KR 1020050085718A KR 20050085718 A KR20050085718 A KR 20050085718A KR 100754953 B1 KR100754953 B1 KR 100754953B1
- Authority
- KR
- South Korea
- Prior art keywords
- coq10
- macrogol
- solubilized
- solubilizer
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
가용화제 | A | B | |
실시예 1 | Macrogol 15 Hydroxystearate | 주황색의 투명액 | 노란색의 투명액 |
비교예 1 | Caprylocaproyl Macrogol Glycerides | 주황색의 투명액 | 노란색의 유탁액 |
비교예 2 | Oleoyl Macrogol Glycerides | 주황색의 투명액 | 노란색의 유탁액 |
비교예 3 | Polyoxyl 35 castor oil | 주황색의 투명액 | 노란색의 투명액 |
비교예 4 | Polysorbate 80 | 주황색의 투명액 | 노란색의 투명액 |
비교예 5 | Medium-chain Triglycerides | 주황색의 투명액 | 물층과 분리 |
비교예 6 | Diethylene Glycol Monoethyl Ether | 주황색의 투명액 | 노란색의 유탁액 |
비교예 7 | Propylene glycol | 불투명, 침전형성 | - |
비교예 8 | Dibutyl sebacate | 주황색의 투명액 | 물층과 분리 |
비교예 9 | Lauroyl Macrogol Glycerides | 불투명, 침전형성 | - |
실시예 2 | 비교예 10 | 비교예 11 | ||
처방 | CoQ10 (g) | 0.01 | 0.01 | 0.01 |
Macrogol 15 Hydroxystearate (g) | 0.04 | - | - | |
Polyoxyl 35 castor oil (g) | - | 0.04 | - | |
Polysorbate 80 (g) | - | - | 0.04 | |
드링크제 (ml) | 100 | 100 | 100 | |
성 상 | 노란색의 투명액 | 노란색의 불투명액 | 노란색의 불투명액 | |
침전 및 부유물 | 없음 | 부유물형성 | 부유물형성 | |
투과율(%) | 94.1 | 76.2 | 65.7 | |
관능검사 (맛과 복용감) | A | B | C |
실시예 | ||||||
3 | 4 | 5 | 6 | 7 | ||
처방 | CoQ10 (g) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Macrogol 15 Hydroxystearate (g) | 2 | 1.5 | 1.0 | 0.5 | 0.4 | |
정제수 (ml) | 1000 | 1000 | 1000 | 1000 | 1000 | |
성 상 | 노란색 투명액 | 노란색 투명액 | 노란색 투명액 | 노란색 투명액 | 노란색 투명액 | |
투과율(%) | 99.1 | 98.8 | 97.3 | 96.9 | 94.7 | |
관능검사(맛과 복용감) | B | B | A | A | A |
Claims (8)
- 삭제
- 삭제
- 삭제
- 삭제
- 정제수 또는 수성 액제에 유비데카레논 및 매크로골 15 히드록시스테아르산을 포함하는 가용화물이 가용화된 형태의 유비데카레논 함유 액상 제제.
- 제5항에 있어서, 유비데카레논의 함유량이 0.0005 내지 5w/v%인 액상 제제.
- 제6항에 있어서, 유비데카레논의 함유량이 0.001 내지 1w/v%인 액상 제제.
- 매크로골 15 히드록시스테아르산 1 내지 20 중량부를 50℃ 이상으로 가열하고, 유비데카레논 1 중량부를 첨가하여 가용화물을 형성하는 단계를 포함하는 가용화물의 제조방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050085718A KR100754953B1 (ko) | 2005-09-14 | 2005-09-14 | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 |
PCT/KR2006/003649 WO2007032643A1 (en) | 2005-09-14 | 2006-09-14 | A solubilized material comprising ubidecarenone, aqueous solution and process for preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050085718A KR100754953B1 (ko) | 2005-09-14 | 2005-09-14 | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070031065A KR20070031065A (ko) | 2007-03-19 |
KR100754953B1 true KR100754953B1 (ko) | 2007-09-04 |
Family
ID=37865185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050085718A KR100754953B1 (ko) | 2005-09-14 | 2005-09-14 | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100754953B1 (ko) |
WO (1) | WO2007032643A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113440483B (zh) * | 2021-06-30 | 2023-04-07 | 佛山市南海东方澳龙制药有限公司 | 一种犬用盐酸特比萘芬喷剂及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986004503A1 (en) | 1985-02-01 | 1986-08-14 | Zambon S.P.A. | Pharmaceutical composition containing ubidecarenone |
WO2002024184A2 (de) | 2000-09-19 | 2002-03-28 | Abbott Gmbh & Co. Kg | Mechanisch stabile darreichungsformen, enthaltend ubichinone |
US20040076675A1 (en) | 2000-12-01 | 2004-04-22 | Jun Sugishita | Composition improved in solubility or oral absorbability |
US6923988B2 (en) | 1999-11-23 | 2005-08-02 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
KR20050084126A (ko) * | 2002-12-04 | 2005-08-26 | 닛신 파마 가부시키가이샤 | 코엔자임 q10 을 함유하는 수용성 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2513276C (en) * | 2003-01-17 | 2012-09-04 | Taiyo Kagaku Co., Ltd. | Compositions containing coenzyme q10 |
-
2005
- 2005-09-14 KR KR1020050085718A patent/KR100754953B1/ko active IP Right Grant
-
2006
- 2006-09-14 WO PCT/KR2006/003649 patent/WO2007032643A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986004503A1 (en) | 1985-02-01 | 1986-08-14 | Zambon S.P.A. | Pharmaceutical composition containing ubidecarenone |
US6923988B2 (en) | 1999-11-23 | 2005-08-02 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2002024184A2 (de) | 2000-09-19 | 2002-03-28 | Abbott Gmbh & Co. Kg | Mechanisch stabile darreichungsformen, enthaltend ubichinone |
US20040076675A1 (en) | 2000-12-01 | 2004-04-22 | Jun Sugishita | Composition improved in solubility or oral absorbability |
KR20050084126A (ko) * | 2002-12-04 | 2005-08-26 | 닛신 파마 가부시키가이샤 | 코엔자임 q10 을 함유하는 수용성 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20070031065A (ko) | 2007-03-19 |
WO2007032643A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101025641B1 (ko) | 매스틱 자가유화에멀젼 조성물 및 이를 함유하는 캡슐 | |
JP2006508104A (ja) | 難溶性風邪薬の経口投与用マイクロエマルション濃縮液及びその製造方法 | |
RU2761967C2 (ru) | Способ лечения, включающий пероральное или желудочное введение эдаравона | |
US11147810B2 (en) | Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents | |
WO2006080903A3 (en) | High concentration self-microemulsifying coenzyme q10 preparations for nutritional use | |
JP2009256216A (ja) | 溶液状態で安定なアムロジピンベシル酸塩内服用液剤 | |
CN115605207A (zh) | 用于经粘膜给药的固体剂型 | |
KR100754953B1 (ko) | 유비데카레논을 함유한 가용화물, 액상 제제 및 그 제조 방법 | |
BR112019014712A2 (pt) | Tratamento médio que compreende a administração entérica de edaravona | |
JP2001010977A (ja) | 経口用組成物 | |
US20040033257A1 (en) | Pharmaceutical formulation in a drug delivery system and process for preparing the same | |
JP2007269786A (ja) | パンテチン含有経口液剤 | |
TW202320774A (zh) | 用於口服之舒緩肽b2受體拮抗劑之基於脂質之組成物 | |
JP2948111B2 (ja) | 経口投与用油性組成物 | |
KR102556874B1 (ko) | 비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법 | |
KR100825572B1 (ko) | 칼슘, 마그네슘 및 비타민을 포함하는 액제 조성물 및 그의제조방법 | |
EP0119852B1 (en) | Podophyllotoxin preparations for use in the treatment of genital warts | |
KR101297354B1 (ko) | 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물 | |
JP6014252B2 (ja) | ネパデュタントを含有する小児用経口液体組成物 | |
JPS60199814A (ja) | ユビデカレノン脂肪乳剤 | |
KR20190087039A (ko) | 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법 | |
JP2003342186A (ja) | 鼻炎用内服液剤組成物 | |
JP2000219628A (ja) | アラトロフロキサシンの予め混合した注射用組成物 | |
TW528596B (en) | Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors | |
KR100859781B1 (ko) | 유비데카레논-함유 약학 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
G170 | Publication of correction | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 13 |